Resmed Inc. buy JPMorgan Chase & Co.
Start price
24.04.25
/
50%
€208.50
Target price
24.04.26
€255.40
Performance (%)
-3.69%
Price
15:38
€200.80
Summary
This prediction is currently active. With a performance of -3.69%, the BUY prediction for Resmed Inc. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 24.04.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -7.251% | -7.251% |
| iShares Core DAX® | -1.104% | -6.084% |
| iShares Nasdaq 100 | 0.328% | 2.327% |
| iShares Nikkei 225® | -1.082% | -7.987% |
| iShares S&P 500 | -0.055% | 0.880% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $286.00 to $290.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat